Hiba Muwafaq Saleem

Dr. Hiba Muwafaq Saleem


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
HSHiba Muwafaq Saleem
Hiba Muwafaq Saleem
HAHussein Riyadh Abdul Kareem Al-Hetty
Hussein Riyadh Abdul Kareem Al-Hetty
AAAbdulrahman T. Ahmed
Abdulrahman T. Ahmed
MAMuthanna M. Awad
Muthanna M. Awad
MAMohammed Qais Al-Ani
Mohammed Qais Al-Ani
LALoay H. Ali
Loay H. Ali

8 November 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SAsulieman Al-Hawary
sulieman Al-Hawary
ISIbraheem Abdulnabi Shabeeb
Ibraheem Abdulnabi Shabeeb
IAIrfan Ahmad
Irfan Ahmad
HSHiba Muwafaq Saleem
Hiba Muwafaq Saleem
PBPooja Bansal
Pooja Bansal
MAMunther Kadhim Abosaoda
Munther Kadhim Abosaoda

25 May 2024 in PharmaNutrition
Verified
Journal Article
Closed access
HAHussein Riyadh Abdul Kareem Al-Hetty
Hussein Riyadh Abdul Kareem Al-Hetty
AAAbdulrahman T. Ahmed
Abdulrahman T. Ahmed
HSHiba Muwafaq Saleem
Hiba Muwafaq Saleem
HAHaitham L. Abdulhadi
Haitham L. Abdulhadi
TMThikra Majid Muhammed
Thikra Majid Muhammed
LALoay H. Ali
Loay H. Ali

8 June 2026 in Biomarkers in Medicine
Verified
Journal Article
Closed access
HSHiba Muwafaq Saleem
Hiba Muwafaq Saleem
HAHussein Riyadh Abdul Kareem Al-Hetty
Hussein Riyadh Abdul Kareem Al-Hetty
HRHanan Yousif Rasheed
Hanan Yousif Rasheed
RMRuaa Abdulazez Mohammed
Ruaa Abdulazez Mohammed
1. Polycystic ovary syndrome (PCOS) is a systemic endocrine disorder affecting women of reproductive age and is characterized by hormonal imbalances and metabolic dysregulation [1,2]. Clinically, P...

30 April 2026 in Archives of Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HSHiba Muwafaq Saleem
Hiba Muwafaq Saleem
AAAbdulsalam Abdulsattar Abdulazez
Abdulsalam Abdulsattar Abdulazez
SASamer Saleem Alshkarchy
Samer Saleem Alshkarchy
WKWesam R. Kadhum
Wesam R. Kadhum
MRMohammad Rudiansyah
Mohammad Rudiansyah
MMMohammad javad Mohammadi
Mohammad javad Mohammadi
Context: Tuberculosis is an airborne infectious disease influenced by multiple factors. Exposure to air pollutants may aggravate pulmonary tuberculosis. This systematic review examined the increased risk of tuberculosis and its exacerbation associated with exposure to air pollutants. Evidence Acquisition: The review searched PubMed, ScienceDirect, Web of Science, the Cochrane Library, and Google Scholar for studies published from 1995 through 2024 using terms related to air pollution, ambient air, Mycobacterium tuberculosis, the respiratory system, and tuberculosis. The initial search retrieved 404 records. Results: The main symptoms of pulmonary tuberculosis include chills, night sweats, fatigue, fever, chronic hemoptysis, lymphadenopathy, and weight loss. Tuberculosis most commonly affects the lungs, although other organs may also be involved. Environmental agents, including gases and airborne particles, may delay treatment and further damage lung tissue. The reviewed evidence indicates that exposure to certain air pollutants may increase the risk or severity of tuberculosis by impairing immune function and lung health, highlighting air pollution as an important public health concern. Discussion: The findings indicate an association between ambient air pollutant levels and tuberculosis. Air pollutants can damage healthy lung tissue through multiple mechanisms and impair pulmonary defenses against disease, thereby exacerbating conditions such as tuberculosis. Therefore, reducing air pollution may help to lessen the severity of symptoms of respiratory diseases, including tuberculosis.